ACIP 2021 Adult Immunization Schedule Changes: A Quick Take
Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) on February 11, 2021 published its recommended vaccination schedule for adults for 2021.
The recommendations are relatively similar to those made in 2020, but with one vaccine added (the MenACWY-TT vaccine, first licensed in 2020) and one deleted (the zoster vaccine live, removed from the market in 2020). The schedule also includes new or updated recommendations for specific vaccines: hepatitis A (HepA), hepatitis B (Hep B), meningococcal serogroups A, C, W, and Y (MenACYW) vaccines, meningococcal B (MenB) vaccines, pneumococcal, human papillomavirus (HPV), zoster, and influenza.
Click through the short slide show below for the updates, in brief.
Updates to the ACIP 2021 Adult Immunization Schedule
Zoster and HepB - Edits Made to Notes and Tables including removal of live zoster vaccine from the recommendations and use of shared clinical decision making on the HepB vaccine for older adults with diabetes.
HepA and Meningococcal Disease - Edits Made to Notes and Tables including guidance on accelerated dosing of Twinrix for those traveling to high-risk regions and on booster doses of MenB and MenACWY vaccines for special populations and those in an outbreak situation.
Pneumococcal Edits Made to Notes to include a link to the CDC revised recommendation for routine pneumococcal vaccination for persons aged ≥65 yrs. PCV13 is no longer routinely recommended and is replaced by routine use of PPSV23. Shared clinical decision making between patient and clinician is recommended regarding use of PCV13 and guidance follows on administration.
Pneumococcal Edits to Notes provides guidance on how to proceed if planning to administer both PCV13 and PPSV23.
HPV Edits to Notes included new language under Shared Decision Making including that catch-up vaccination can be considered with shared decision making for those aged 27 through 45 yrs.
Influenza Added under Special Situations is guidance on how to proceed with patients who show symptoms of egg allergy other than hives and also reminders to clinicians that severe allergic reactions can occur even in the absence of history and that any previous reaction of this nature is a contraindication to future receipt of the vaccine.
